Wand, Hannah
Lambert, Samuel A. http://orcid.org/0000-0001-8222-008X
Tamburro, Cecelia
Iacocca, Michael A.
O’Sullivan, Jack W.
Sillari, Catherine
Kullo, Iftikhar J. http://orcid.org/0000-0002-6524-3471
Rowley, Robb
Dron, Jacqueline S. http://orcid.org/0000-0002-3045-6530
Brockman, Deanna
Venner, Eric
McCarthy, Mark I. http://orcid.org/0000-0002-4393-0510
Antoniou, Antonis C.
Easton, Douglas F. http://orcid.org/0000-0003-2444-3247
Hegele, Robert A.
Khera, Amit V. http://orcid.org/0000-0001-6535-5839
Chatterjee, Nilanjan
Kooperberg, Charles
Edwards, Karen
Vlessis, Katherine
Kinnear, Kim
Danesh, John N.
Parkinson, Helen
Ramos, Erin M.
Roberts, Megan C.
Ormond, Kelly E. http://orcid.org/0000-0002-1033-0818
Khoury, Muin J.
Janssens, A. Cecile J. W.
Goddard, Katrina A. B.
Kraft, Peter http://orcid.org/0000-0002-4472-8103
MacArthur, Jaqueline A. L. http://orcid.org/0000-0002-3550-9769
Inouye, Michael http://orcid.org/0000-0001-9413-6520
Wojcik, Genevieve L. http://orcid.org/0000-0001-7206-8088
Article History
Received: 20 April 2020
Accepted: 15 January 2021
First Online: 10 March 2021
Competing interests
: M.I.M. is on the advisory panels for Pfizer, Novo Nordisk and Zoe Global; honoraria: Merck, Pfizer, Novo Nordisk and Eli Lilly; research funding: Abbvie, Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Merck, Novo Nordisk, Pfizer, Roche, Sanofi Aventis, Servier and Takeda. As of June 2019, he is an employee of Genentech with stock and stock options in Roche. No other authors have competing interests to declare.